Viagra Video in your language:

English translation of Viagra Video - the sexual health and male enhancement video blogChinese (Simplified) translation of Viagra Video - the sexual health and male enhancement video blogDutch translation of Viagra Video - the sexual health and male enhancement video blogFrench translation of Viagra Video - the sexual health and male enhancement video blogGerman translation of Viagra Video - the sexual health and male enhancement video blogGreek translation of Viagra Video - the sexual health and male enhancement video blogItalian translation of Viagra Video - the sexual health and male enhancement video blogJapanese translation of Viagra Video - the sexual health and male enhancement video blogKorean translation of Viagra Video - the sexual health and male enhancement video blogPortuguese translation of Viagra Video - the sexual health and male enhancement video blogRussian translation of Viagra Video - the sexual health and male enhancement video blogSpanish translation of Viagra Video - the sexual health and male enhancement video blog

FDA Warning: New Risks when using ED drugs Viagra, Levitra and Cialis

Insidermedicine in 60 (seconds), a short medical news compilation from California, reports in its latest feature about new FDA warnings. The last topic describes why new warning labels are being added to Viagra and other FDA approved pharmaceutical erectile dysfunction (ED) drugs due to 29 cases of hearing loss within 2 days of taking Viagra, Levitra or Cialis.

Meanwhile the number of cases is growing due to Viagra and other ED related pharmacy being a defective drug.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Technorati
  • Furl
  • Netscape
  • YahooMyWeb
StumbleUpon It!

Tags: , , , , , , , , ,



Related posts

Posted in Medical Sexual Health   

Insane $75 discount on 1 year webhosting?
Sign up with promo code "vidude":


Get DreamHost webhosting with insane discount!

No comments yet. Be the first.

Leave a reply